Skip to main content

Table 2 Paraclinical findings in 80 pregnant women with confirmed SARS-CoV-2 infection in Venezuela

From: Clinical-epidemiological characteristics and maternal-foetal outcomes in pregnant women hospitalised with COVID-19 in Venezuela: a retrospective study

 

All (N = 80)

Survivors (N = 59)

Dead (N = 21)

p-value

Haemoglobin, median (IQR), g/dL (n = 66)

10.9 (9.8–11.5)

11 (9.8–11.8)

10.7 (9.7–11)

0.619*

Haematocrit, median (IQR), % (n = 66)

33 (29.6–35.9)

33 (30–36)

32 (29.4–34)

0.694*

Leukocytes, median (IQR), × 103/mL (n = 66)

9.5 (7.7–12.9)

9.5 (7.7–12.9)

9.2 (8.3–12.6)

1*

Neutrophils, mean (SD), ×103/mL (n = 66)

78 (10)

78 (10)

82 (8)

0.61

Lymphocytes, mean (SD), ×103/mL (n = 66)

21 (10)

20 (11)

17 (16)

0.63

Platelets, median (IQR), ×103/mL (n = 66)

185 (155–222)

187 (165–220)

150 (138–245)

0.619*

Glycaemia, mean (SD), mg/dL (n = 46)

93 (19)

89 (18)

103 (18)

0.769

Urea, median (IQR), mg/dL (n = 36)

20.5 (15.5–34)

20 (14–28.5)

22 (15–45)

0.289*

Creatinine, median (IQR), mg/dL (n = 36)

0.8 (0.7–1)

0.8 (0.7–0.9)

0.9 (0.7–1.4)

0.724*

PT, median (IQR), seconds (n = 14)

12.4 (12–15)

12.9 (11.3–15.8)

12.0 (11.3–12.8)

0.559*

PTT, median (IQR), seconds (n = 14)

31.4 (30–33.2)

32.4 (30–33.2)

29 (27.5–32.5)

0.263*

AST, mean (SD), mg/dL (n = 13)

51.5 (19.2)

50.4 (20.8)

57.5 (4.9)

0.152

ALT, mean (SD), mg/dL (n = 13)

49.3 (23.8)

51.2 (25.4)

38.5 (7.8)

0.194

LDH, median (IQR), mg/dL (n = 53)

301 (180–587)

258 (163–557)

482 (297–1520)

0.263*

D-dimer, median (IQR), ng/dL (n = 42)

19.0 (11.1–22.9)

19.2 (11.1–22.6)

18.9 (12.9–27.2)

0.717*

Ferritin, median (IQR), ng/dL (n = 42)

288 (180–450)

280 (180–410)

320 (200–689)

0.452*

  1. *Median test
  2. Student’s t-test
  3. IQR interquartile range, PT prothrombin time, PTT partial thromboplastin time, LDH lactate dehydrogenase